Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 68M
46.26x6.17x-0.74x5.15x21.74x29.87x2.67% 310B
24.41x2.05x-18.28x3.34x11.92x19.49x1.61% 71.56B
11.44x12.1x0.07x5.82x8.97x9.85x - 9.13B
16.66x1.44x0.83x2.11x7.24x8.64x2.68% 8.27B
23.13x6.15x2.32x6.6x18.65x19.5x-.--% 4.38B
36.34x - 0.23x6.86x19.6x31.76x - 4.21B
39.14x2.33x-1.27x2.21x27.03x40.65x0.79% 3.39B
109.41x - -0.67x - - - -.--% 2.75B
16.79x0.73x-0.61x1.3x23.26x39.81x4.21% 1.03B
50.64x - -0.1x - - - - 1B
-7.35x12.28x0.45x201.48x-6.53x-5.07x-.--% 944M
43.7x6.85x-1.13x14.54x30.52x35.91x - 907M
Average 34.21x 5.57x -1.57x 24.94x 16.24x 23.04x 1.5% 32.1B
Weighted average by Cap. 40.99x 5.46x -3.65x 5.26x 19.42x 27.17x 2.42%
Specialty & Advanced Pharmaceuticals